Constitutive or Induced HIF-2 Addiction is Involved in Resistance to Anti-EGFR Treatment and Radiation Therapy in HNSCC.

Coliat, Pierre; Ramolu, Ludivine; Jégu, Jérémie; Gaiddon, Christian; Jung, Alain C; Pencreach, Erwan

Coliat, Pierre; Ramolu, Ludivine; Jégu, Jérémie; Gaiddon, Christian; Jung, Alain C; Pencreach, Erwan.

Afiliação

Coliat P; Centre de Lutte Contre le Cancer Paul Strauss, 67200 Strasbourg, France. pcoliat@strasbourg.unicancer.fr.
Ramolu L; Service de Pharmacie, Centre de Lutte Contre le Cancer Paul Strauss, 67200 Strasbourg, France. pcoliat@strasbourg.unicancer.fr.
Jégu J; Université de Strasbourg, Inserm, UMR_S1113, 67200 Strasbourg, France. pcoliat@strasbourg.unicancer.fr.
Gaiddon C; Centre de Lutte Contre le Cancer Paul Strauss, 67200 Strasbourg, France. lramolu@unistra.fr.
Jung AC; Université de Strasbourg, Inserm, UMR_S1113, 67200 Strasbourg, France. lramolu@unistra.fr.
Pencreach E; Université de Strasbourg, Inserm, UMR_S1113, 67200 Strasbourg, France. jeremie.jegu@unistra.fr.

Cancers (Basel) ; 11(10)2019 Oct 21.

Article em En | MEDLINE | ID: mdl-31640284

Palavras-chave

HIF-2α; anti-EGFR targeted therapy; head and neck squamous cell carcinoma; oncogenic addiction; resistance

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google